Ardelyx, Inc.

Ardelyx, Inc.verified

ARDX

Price:

$4.64

Market Cap:

$1.10B

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or hear...[Read more]

Industry

Biotechnology

IPO Date

2014-06-19

Stock Exchange

NASDAQ

Ticker

ARDX

The Current Ratio as of December 2024 (TTM) for Ardelyx, Inc. (ARDX) is 4.03

According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.03. This represents a change of -8.72% compared to the average of 4.41 of the last 4 quarters.

Ardelyx, Inc. (ARDX) Historical Current Ratio (quarterly & annually)

How has ARDX Current Ratio performed in the past?

The mean historical Current Ratio of Ardelyx, Inc. over the last ten years is 9.11. The current 4.03 Current Ratio has changed 4.32% with respect to the historical average. Over the past ten years (40 quarters), ARDX's Current Ratio was at its highest in in the June 2015 quarter at 25.95. The Current Ratio was at its lowest in in the December 2022 quarter at 2.07.

Quarterly (TTM)
Annual

Average

9.11

Median

9.21

Minimum

2.07

Maximum

20.03

Ardelyx, Inc. (ARDX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ardelyx, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 720.40%

Maximum Annual Current Ratio = 20.03

Minimum Annual Increase = -65.91%

Minimum Annual Current Ratio = 2.07

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.88135.93%
20222.07-11.63%
20212.34-65.91%
20206.87-39.51%
201911.3613.30%
201810.0219.54%
20178.39-21.06%
201610.62-26.90%
201514.53-27.43%
201420.03720.40%

Ardelyx, Inc. (ARDX) Average Current Ratio

How has ARDX Current Ratio performed in the past?

The current Current Ratio of Ardelyx, Inc. (ARDX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.10

5-year avg

5.51

10-year avg

9.11

Ardelyx, Inc. (ARDX) Current Ratio vs. Peers

How is ARDX’s Current Ratio compared to its peers?

Ardelyx, Inc.’s Current Ratio is greater than BioLineRx Ltd. (1.52), less than Lexicon Pharmaceuticals, Inc. (7.45), greater than Seres Therapeutics, Inc. (1.12), greater than ImmunityBio, Inc. (2.68), less than Zura Bio Limited (0), less than Hepion Pharmaceuticals, Inc. (10.36), greater than AVROBIO, Inc. (1.30), less than Verastem, Inc. (26.17), greater than Mereo BioPharma Group plc (3.23), less than Terns Pharmaceuticals, Inc. (6.10), less than PDS Biotechnology Corporation (32.99), greater than Inozyme Pharma, Inc. (2.84), less than HOOKIPA Pharma Inc. (7.68), greater than null (3.26),

Build a custom stock screener for Ardelyx, Inc. (ARDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ardelyx, Inc. (ARDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Ardelyx, Inc.'s Current Ratio?

How is the Current Ratio calculated for Ardelyx, Inc. (ARDX)?

What is the highest Current Ratio for Ardelyx, Inc. (ARDX)?

What is the 3-year average Current Ratio for Ardelyx, Inc. (ARDX)?

What is the 5-year average Current Ratio for Ardelyx, Inc. (ARDX)?

How does the current Current Ratio for Ardelyx, Inc. (ARDX) compare to its historical average?